Serum S100-Beta as a Biomarker for Neurological Recovery in Acute Spinal Cord Injury (ASCI): A Prospective Case-Control Study
S100B is a promising biomarker for early ASCI severity and recovery. However, further large-scale studies are required to establish its clinical utility.
Authors
- Uday Raj
- Binod Kumar (ORCID: https://orcid.org/0000-0002-2077-8501)
- Shah Waliullah (ORCID: https://orcid.org/0000-0001-5621-4751)
- Nagendra Kumar (ORCID: https://orcid.org/0000-0003-0079-3445)
- Zeenat Ara (ORCID: https://orcid.org/0000-0002-4164-2216)
- Bhavesh Kumar (ORCID: https://orcid.org/0000-0002-2304-4909)
- Devarshi Rastogi
Institutions
- King George's Medical University (IN)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-18
- DOI
- https://doi.org/10.7759/cureus.79202
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 0.00